Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium.
Vermeiren E, van Loenhout JAF, Nasiadka L, Stouten V, Billuart M, Van Evercooren I, Catteau L, Hubin P. Vermeiren E, et al. Among authors: hubin p. BMC Res Notes. 2023 Nov 11;16(1):328. doi: 10.1186/s13104-023-06608-4. BMC Res Notes. 2023. PMID: 37951923 Free PMC article.
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.
Braeye T, Catteau L, Brondeel R, van Loenhout JAF, Proesmans K, Cornelissen L, Van Oyen H, Stouten V, Hubin P, Billuart M, Djiena A, Mahieu R, Hammami N, Van Cauteren D, Wyndham-Thomas C. Braeye T, et al. Among authors: hubin p. Vaccine. 2023 May 11;41(20):3292-3300. doi: 10.1016/j.vaccine.2023.03.069. Epub 2023 Apr 5. Vaccine. 2023. PMID: 37085456 Free PMC article.
Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.
Cavillot L, van Loenhout JAF, Devleesschauwer B, Wyndham-Thomas C, Van Oyen H, Ghattas J, Blot K, Van den Borre L, Billuart M, Speybroeck N, De Pauw R, Stouten V, Catteau L, Hubin P. Cavillot L, et al. Among authors: hubin p. J Epidemiol Community Health. 2023 Dec 26:jech-2023-220751. doi: 10.1136/jech-2023-220751. Online ahead of print. J Epidemiol Community Health. 2023. PMID: 38148149 Free article.
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Braeye T, Catteau L, Brondeel R, van Loenhout JAF, Proesmans K, Cornelissen L, Van Oyen H, Stouten V, Hubin P, Billuart M, Djiena A, Mahieu R, Hammami N, Van Cauteren D, Wyndham-Thomas C. Braeye T, et al. Among authors: hubin p. Vaccine. 2022 May 11;40(22):3027-3037. doi: 10.1016/j.vaccine.2022.04.025. Epub 2022 Apr 12. Vaccine. 2022. PMID: 35459558 Free PMC article.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Kislaya I, Sentís A, Starrfelt J, Nunes B, Martínez-Baz I, Nielsen KF, AlKerwi A, Braeye T, Fontán-Vela M, Bacci S, Meijerink H, Castilla J, Emborg HD, Hansen CH, Schmitz S, Van Evercooren I, Valenciano M, Nardone A, Nicolay N, Monge S; VEBIS‐Lot4 working group. Kislaya I, et al. Influenza Other Respir Viruses. 2023 Nov;17(11):e13195. doi: 10.1111/irv.13195. Influenza Other Respir Viruses. 2023. PMID: 38019704 Free PMC article.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Fontán-Vela M, Kissling E, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Fabiani M, Mateo-Urdiales A, AlKerwi A, Schmitz S, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Starrfelt J, Nunes B, Caetano C, Derrough T, Nardone A, Monge S; VEBIS-Lot4 working group; VEBIS-Lot 4 working group. Fontán-Vela M, et al. Euro Surveill. 2024 Jan;29(1):2300670. doi: 10.2807/1560-7917.ES.2024.29.1.2300670. Euro Surveill. 2024. PMID: 38179626 Free PMC article.
11 results